MONMOUTH JUNCTION, N.J. (AP) _ CytoSorbents Corp. (CTSO) on Tuesday reported a loss of $4.9 million in its first quarter.
The Monmouth Junction, New Jersey-based company said it had a loss of 15 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 18 cents per share.
The blood purification therapy company posted revenue of $5.2 million in the period, which missed Street forecasts. Three analysts surveyed by Zacks expected $6 million.
CytoSorbents shares have decreased slightly more than 6% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $7.57, a decrease of slightly more than 5% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CTSO at https://www.zacks.com/ap/CTSO